切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2022, Vol. 16 ›› Issue (02) : 137 -141. doi: 10.3877/cma.j.issn.1674-3946.2022.02.007

论著

评估应用术前PLR、NLR及AGR预测乳腺癌患者预后的价值
孙曼迪1, 符德元1,()   
  1. 1. 225001 江苏扬州,苏北人民医院甲状腺乳腺外科
  • 收稿日期:2021-04-10 出版日期:2022-04-26
  • 通信作者: 符德元

Evaluate the prognostic value of preoperative PLR,NLR and AGR in breast cancer patients

Mandi Sun1, Deyuan Fu1,()   

  1. 1. Department of Thyroid and Breast Surgery, Northern Jiangsu People’s Hospital, Yangzhou Jiangsu Province 225001, China
  • Received:2021-04-10 Published:2022-04-26
  • Corresponding author: Deyuan Fu
  • Supported by:
    National Nature Science Foundation(82072909); the 16th“Summit of the Six Top Talents” Program of Jiangsu Province(YY-217); Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province(CXPJJH11900002-014); Jiangsu Province 333 Talents Project(BRA2019182)
引用本文:

孙曼迪, 符德元. 评估应用术前PLR、NLR及AGR预测乳腺癌患者预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2022, 16(02): 137-141.

Mandi Sun, Deyuan Fu. Evaluate the prognostic value of preoperative PLR,NLR and AGR in breast cancer patients[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2022, 16(02): 137-141.

目的

探究术前血小板淋巴细胞比值(PLR)、中性粒细胞淋巴细胞比值(NLR)及白蛋白球蛋白比值(AGR)在评估乳腺癌患者预后中的价值。

方法

选取2013年1月至2017年12月收治的1184例浸润性乳腺癌女性患者为浸润性乳腺癌组,随机选取仅患乳腺纤维腺瘤的患者279例为乳腺纤维腺瘤组。收集患者一般资料、术后病理资料、血型、术前外周血血小板、中性粒细胞、淋巴细胞数量以及血清白蛋白和球蛋白水平,并计算得出PLR、NLR及AGR。应用受试者功能特征曲线下面积来评估三者预测乳腺癌患者预后的能力。本研究使用SPSS 20.0及MedCalc软件进行统计学分析和绘图,P<0.05代表差异具有统计学意义。

结果

浸润性乳腺癌患者的术前PLR及NLR均值显著高于乳腺纤维腺瘤患者(P<0.05),而AGR低于乳腺纤维腺瘤患者(P<0.05)。Cox比例回归风险分析显示,患者的诊断年龄、PLR、NLR、AGR、肿瘤直径、组织学分级、阳性淋巴结个数和分子分型均为乳腺癌的预后危险因素(P<0.05)。ROC曲线分析结果得出,PLR、NLR及AGR的最佳诊断临界值分别为147.4、2.9及1.7。应用术前PLR(AUC=0.796,P<0.001)、NLR(AUC=0.716,P<0.001)及AGR(AUC=0.748,P<0.001)预测乳腺癌患者预后均有价值,且PLR价值更高。

结论

术前PLR、NLR及AGR对乳腺癌患者预后的判断均具价值,三者相比,PLR价值更高,有望成为判断乳腺癌患者预后的补充指标。

Objective

To investigate the value of platelet lymphocyte ratio(PLR),neutrophilic lymphocyte ratio(NLR)and albumin to globulin ratio(AGR)in evaluating the prognosis of breast cancer patients.

Methods

1184 female patients with invasive breast cancer admitted from January 2013 to December 2017 were selected as the invasive breast cancer group,279 patients with breast fibroadenoma were randomly selected as breast fibroadenoma group. General data,postoperative pathological data,blood type,preoperative peripheral blood platelets,neutrophils,lymphocytes,serum albumin and globulin levels were collected. PLR,NLR and AGR were calculated. The area under the receiver functional characteristic curve was used to evaluate the prognostic ability of the three groups. I SPSS 20.0 and MedCalc software were used for statistical analysis and plotting,and P<0.05 indicated statistically significant differences.

Results

The preoperative PLR and NLR of the invasive breast cancer patients were significantly higher than those of the breast fibroadenoma patients(P<0.05),while the AGR was lower than those in patients with breast fibroadenoma(P<0.05).Cox proportional regression risk analysis showed that age at PLR,NLR,AGR,tumor diameter,histological grade,number of positive lymph nodes and molecular type were all prognostic risk factors for breast cancer(P<0.05). ROC curve analysis shouwed that the optimal diagnostic thresholds for PLR,NLR and AGR were 147.4,2.9 and 1.7.Preoperative PLR(AUC=0.796,P<0.001),NLR(AUC=0.716,P<0.001)and AGR(AUC=0.748,P<0.001)were all valuable in predicting the prognosis of breast cancer patients,and the value of PLR is higher.

Conclusion

Preoperative PLR,NLR and AGR are all valuable for the prognosis of breast cancer patients. Compared with the three ratios,PLR has higher value and is expected to be a supplementary indicator for the prognosis of breast cancer patients.

表1 1184例浸润性乳腺癌患者的基线资料
表2 浸润性乳腺癌与乳腺纤维腺瘤患者术前PLR、NLR及AGR的比较
图2 术前PLR、NLR及AGR预测Luminal A型乳腺癌患者预后的ROC曲线对比
图5 术前PLR、NLR及AGR预测TNBC型乳腺癌患者预后的ROC曲线对比
表3 1184例浸润性乳腺癌患者总生存与临床及病理因素的关系
[1]
Bray F,,Ferlay J,,Soerjomataram I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:A Cancer Journal for Clinicians201868(6):394-424.
[2]
Franco PIR,,Rodrigues AP,,de Menezes LB,et al. Tumor microenvironment components:Allies of cancer progression[J]. Pathology Research and Practice2020216(1):152729.
[3]
余亮,汪泳,徐岩岩,等. 术前血小板/淋巴细胞比值对胃癌根治术后病人预后的影响[J]. 临床外科杂志202028(12):1151-1153.
[4]
牟大英,黄露,郝如愚,等. 手术前NLR与上皮性卵巢癌预后的相关性[J]. 中国老年学杂志202141(5):969-972.
[5]
Zhang H,,Zhang B,,Zhu K,et al. Preoperative albumin-to-globulin ratio predicts survival in patients with non-small-cell lung cancer after surgery[J]. J Cell Physiol2019234(3):2471-2479.
[6]
Chung JW,,Park DJ,,Chun SY,et al. The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy[J]. Sci Rep202010(1):11999.
[7]
郭毅. 血小板促进卵巢癌转移的机制研究及其临床应用探讨[D]. 北京:北京协和医学院,2019:1-142.
[8]
Tamura R,,Tanaka T,,Akasaki Y,et al. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment:perspectives for therapeutic implications[J]. Med Oncol201937(1):2.
[9]
Ren X,,Li L,,Wu J,et al. PDGF-BB regulates the transformation of fibroblasts into cancer-associated fibroblasts via the lncRNA LURAP1L-AS1/LURAP1L/IKK/IκB/NF-κB signaling pathway[J]. Oncol Lett202122(1):537.
[10]
Siddhartha R,,Garg M. Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions[J]. Toxicol Appl Pharmacol2021426:115593.
[11]
Parekh A,,Das S,,Parida S,et al. Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo[J]. Oncogene201837(33):4546-4561.
[12]
Jung S,,Baek JH. The Potential of T Cell Factor 1 in Sustaining CD8+ T Lymphocyte-Directed Anti-Tumor Immunity[J]. Cancers(Basel)202113(3):515.
[13]
Seaton K. Albumin concentration controls cancer[J]. J Natl Med Assoc200193(12):490-493.
[14]
Yoshino Y,,Taguchi A,,Shimizuguchi T,et al. A low albumin to globulin ratio with a high serum globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy[J]. Int J Gynecol Cancer201929(1):17-22.
[15]
Pirozzolo G,,Gisbertz SS,,Castoro C,et al. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer:a systematic review and meta-analysis[J]. J Thoracic Dis201911(7):3136-3145.
[16]
黄涛,唐钢. 胃癌患者术前中性粒细胞淋巴细胞比、血小板淋巴细胞比对淋巴结转移预测价值[J/CD]. 中华普外科手术学杂志(电子版)201913(2):141-143.
[17]
Zhou T,,Yu S-T,,Chen W-Z,et al. Pretreatment albumin globulin ratio has a superior prognostic value in laryngeal squamous cell carcinoma patients:a comparison study[J]. J Cancer201910(3):594-601.
[18]
梅章懿,蒋蓓琦,安敏,等. 中性粒细胞淋巴细胞比及血小板淋巴细胞比预测乳腺癌非前哨淋巴结转移的价值分析[J]. 现代肿瘤医学202129(6):955-960.
[1] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[2] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[5] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[6] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[7] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[8] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[9] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[10] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[11] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[12] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[13] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[14] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要